Results 121 to 130 of about 11,825 (179)

Reactive oxygen species promotion drives auranofin's antiviral activity against hepatitis E virus. [PDF]

J Virol
Tiller K, Williams ST, Wang B, Tian D, Meng X-J, Weger-Lucarelli J.   +5 more
europepmc   +1 more source

Prevention: the hib vaccine.

Canadian family physician Medecin de famille canadien, 2013
openaire   +1 more source

The future of Hib vaccines.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2007
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Conjugate Hib vaccines

Lancet, The, 2003
David Goldblatt
exaly   +3 more sources

Biological activity of Hib conjugates

Vaccine, 1991
Haemophilus influenzae type b (Hib) conjugate vaccines dramatically improve the immunogenicity against the capsular polysaccharide (PRP) of Hib. A new Hib conjugate, PedvaxHIB, is shown to be immunogenic in infant rhesus monkeys. The monkey model appears to correlate well with the immunogenicity of PedvaxHIB in human clinical studies.
P P, Vella, J M, Staub, R W, Ellis
openaire   +2 more sources

Predictable success of Hib vaccine

Nursing Standard, 1993
It is of course wonderful news that the introduction of the Hib immunisation programme has cut the number of Hib meningitis cases by 70 per cent and that almost three-quarters of parents have responded to the campaign promoting the vaccine (News, 12 May).
openaire   +2 more sources

Hib-EuroSud'95: the South exists

Vaccine, 1996
TO BE ...
Barquet N., Aristegui J., Ruiz-Contreras J., Hernandez-Sampelayo T., Sorice F., Fara G. M., Vierucci A., Kattamis C., Valente P.   +8 more
openaire   +3 more sources

[Hib vaccine].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Haemophilus influenzae type b (Hib) is the most common cause of bacterial meningitis among children. Hib conjugate vaccines, capsule polysaccharide (polyribosylribitol phosphate: PRP) conjugated with carrier protein, are very effective and safe. Hib vaccine conjugated with tetanus toxoid (PRP-T: ActHIB) was licensed in 1992 in France.
openaire   +1 more source

Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use

Clinical Microbiology Reviews, 2021
Keith Grimwood, Mary Slack
exaly